Unknown

Dataset Information

Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy.


ABSTRACT:

SUBMITTER: Yacyshyn MB 

PROVIDER: S-EPMC8964506 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature